Home General Biotechnology Drug Patent Expirations in September 2014

Drug Patent Expirations in September 2014

Drug Patent Expirations for September 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
COMBIVENT RESPIMATBoehringer Ingelheimalbuterol sulfate; ipratropium bromide5,662,271Sep 2, 2014
BONIVARocheibandronate sodium5,662,918Sep 2, 2014
HEPSERAGileadadefovir dipivoxil5,663,159Sep 2, 2014
VIGAMOXAlcon Pharms Ltdmoxifloxacin hydrochloride5,607,942*PEDSep 4, 2014
MOXEZAAlcon Pharms Ltdmoxifloxacin hydrochloride5,607,942*PEDSep 4, 2014
ALINIARomarknitazoxanide6,020,353Sep 8, 2014
ALINIARomarknitazoxanide5,578,621Sep 8, 2014
PROTOPICAstellastacrolimus5,665,727Sep 9, 2014
RENVELAGenzymesevelamer carbonate5,667,775Sep 16, 2014
RENAGELGenzymesevelamer hydrochloride5,667,775Sep 16, 2014
ALINIARomarknitazoxanide6,020,353Sep 18, 2014
EXUBERAPfizerinsulin recombinant human6,543,448Sep 21, 2014
ATRALINDow Pharmtretinoin5,670,547Sep 23, 2014
NAROPINFresenius Kabi Usaropivacaine hydrochloride5,670,524Sep 23, 2014
NEORALNovartiscyclosporine5,985,321Sep 26, 2014
IONSYSIncline Therapfentanyl hydrochloride7,027,859Sep 26, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.